Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GAND-emesis antiemetic regimen study in cervical cancer chemoradiotherapy
2009-014691-21Phase 3Completed
- Sponsor
- University Hospital Odense
- Start
- Jan 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of fosaprepitant, palonosetron and dexamethasone in Nausea and Vomiting (2 arms), sponsored by University Hospital Odense. Primary endpoint: Sustained no emesis rate. Started Jan 2010; status: completed.
02
Drugs
fosaprepitantpalonosetrondexamethasone
03
Conditions
Nausea and Vomiting
Beyond the preview
Go deeper on 2009-014691-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014691-21.